On-Demand Webinar: Emergency Use Authorization for COVID-19 Tests 20 Months Into the Pandemic

2022-02-08T00:47:08+00:00By Jo-Ann F. Gonzales, RAC, Director IVD Regulatory & Quality Consulting, Precision for Medicine|

As the demand for COVID-19 diagnostic tests soar, the FDA guidelines around emergency-use authorization continue to shift. Discover what has changed and what that means to your FDA approval path in this 30-minute webinar.

FDA priorities
Paths to commercialization
Modifications for use in laboratories and POC
Post-authorization conditions
Links to resources
5 key takeaways

About the speaker:

Experienced Regulatory Affairs professional with a demonstrated history of working in the biotechnology industry. Career has been focused on Medical Devices and IVDs. Strong regulatory professional with over 20 years of experience.

Jo-Ann F. Gonzales, RAC
Director IVD Regulatory & Quality Consulting

View the talk below.

Also in this Issue

Your 2022 Guide to Biospecimen Strategies for Immuno-Oncology R&D

Biospecimens are invaluable in pinpointing de novo therapeutic drug targets; they are also a critical tool for the identification of novel cancer resistance mechanisms and oncogenic pathways. Here, we highlight keys to selecting the biospecimens best suited to drive success for IO research and development. READ MORE
Rare Disease Clinical Trials in Pediatric Populations: Lessons Learned

Rare disease trials are inherently complex. Pediatric rare disease trials compound it further. Having supported 150+ rare disease trials, many for pediatric indications, our Precision experts have detailed advice. Here, Traci Fulton, Executive Director, Project Management, addresses pediatric-specific hurdles and provides strategies to overcome them, including lessons learned during COVID-19. READ MORE
Clinical Research EDC: Tips to Going Live on Time

Electronic data capture (EDC) systems are essential repositories for patient data in clinical trials. As such, their go-live date impacts trial-wide scheduling. In this article, Michelle Martell, Executive Director, Data Management at Precision for Medicine, shares the factors that drive EDC timelines, insights into key aspects of EDC design and build, and vital steps sponsors can take to optimize workflow. READ MORE
On-Demand Webinar: NAb vs TAb Assays in Gene Therapy Development: Key Considerations For Assessing Immunogenicity

With pre-existing immunity to viral vectors presenting a major challenge to the delivery of life-changing gene therapies, developing an assay to assess humoral immunogenicity. But, how can you determine whether a NAb or Tab assay is best? Deb Phippard, PhD, Chief Science Officer, and Travis Harrison, PhD, Vice President, Bioassay Solutions, Precision for Medicine, offer guidance in this must-see webinar. READ MORE
On-Demand Webinar: Data Silos With a Translational Hub

When a network of specialty labs use individual data formats and annotations, the result is translational data chaos—and deep frustration for the researchers who have to manually curate and prepare data. In this 30-minute webinar, QuartzBio experts demonstrate how integrating exploratory biomarker, PK, and clinical data silos in a translational hub enables teams to interrogate trends and identify insights as data is generated on-study. READ MORE